Purchase Order 75F40123P00333
Award Date 8/30/23
Potential Completion Date 9/30/23
Potential Value $10K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Andexxa 200 mg vials, a critical reversal agent used in emergency medical settings. This firm fixed-price delivery order, valued at $8,672.15, represents a competitive award with no set-aside designation and is scheduled for completion by May 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken,...
- This federal contract award, valued at $19,976.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ANDEXXA 200 MG VIALS, a critical medical product, with a completion date of November 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- ASD Specialty Healthcare, LLC, a subsidiary of Cencora, Inc. (operating as AmerisourceBergen), received a firm fixed-price purchase order award from the Department of Veterans Affairs Veterans Integrated Service Network 2 for a pharmacy order of Adstiladrin, a specialty oncology medication. The contract, valued at approximately $46K, was awarded on April 21, 2026, with an ultimate completion date of July 21, 2026. The order will be fulfilled from the contractor's facility in Carrollton, Texas....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ANDEXXA 200 MG VIALS, a specialty medication, at a firm fixed price of $27,555.40. The contract has an ultimate completion date of December 13, 2024 and was awarded on November 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $8,391.55, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,344.30 firm fixed-price contract is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product, with a completion date of July 17, 2025. This contract is not set aside and was awarded on an open competitive basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a firm fixed-price purchase order valued at $45,829.15 to ASD Specialty Healthcare, LLC for the delivery of pharmacy drug Adstiladrin 4x20. Performance will take place in Carrollton, Texas over a period of four days from November 14-17, 2023. ASD Specialty Healthcare, LLC is the prime contractor and will be delivering the requested pharmaceutical products to support the VA's provision...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ANDEXXA 200 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $16,783.10 and was awarded by the Medical Supply Chain, a component of the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 200 mg vials of the pharmaceutical product ANDEXXA, with a ceiling value of $6,658.73. The award was made by the Defense Logistics Agency (DLA), a defense agency, under a Delivery Order contract type with a Firm Fixed Price pricing mechanism. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $8,672.15 firm fixed-price delivery order is for ANDEXXA 200 MG VIALS and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
ASD Specialty Healthcare, LLC, doing business as ASD Specialty Healthcare LLC, has been awarded a $10,300 purchase order contract by the Department of Health and Human Services' Food and Drug Administration to deliver one set of 200mg vials of the pharmaceutical product Andexxa, with each set containing four vials. Place of performance will be Carrollton, Texas. The firm fixed price contract runs from August 30 to September 30, 2023. No subcontractors or set aside designations were identified. This award will provide Andexxa to the FDA to support the agency's regulation and approval of drugs and medical devices intended for human use in the United States.
Generated 12/23/23, 1:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 8/30/23 |